doValue (DOV) Corporate Presentation summary
Event summary combining transcript, slides, and related documents.
Corporate Presentation summary
13 Jun, 2025Key highlights of the business plan
Market leader in NPL collections in Southern Europe with €116bn GBV across four countries and a 15-year average contract life.
Diversified portfolio with 33% of revenues from non-NPL services and over 80% of revenues secured for the next three years.
EBITDA margin at 37% and operating cash flow of €88m, with a net debt/EBITDA ratio of 2.7x.
Strategic focus on asset-light credit management, long-term client relationships, and high revenue visibility.
Three anchor shareholders (Fortress, Elliott, Bain Capital) committed to supporting growth and M&A.
Gardant transaction
Acquisition of Gardant, a leading Italian credit management platform, for €230m cash and 20% ownership in the combined entity.
Gardant brings €22bn GBV, €135m gross revenues, and €50m EBITDA, with 40% of revenues from non-NPL services.
Transaction expected to generate up to €15m annual pre-tax synergies, mainly from cost savings and cross-selling.
Financing includes a €500m package and €150m rights issue, with strong backing from anchor shareholders.
Combined group to achieve over €130bn GBV, enhanced client diversification, and improved leverage (1.3-1.5x by 2026E).
Business plan assumptions and strategy
2024-2026 strategy targets 20% market share, €9bn annual GBV inflows, and 35-40% non-NPL revenues by 2026.
Focus on expanding core credit collection, launching new solutions beyond servicing, and pursuing M&A for growth.
Regional strategies tailored to market maturity: leadership in Greece, specialization in Italy, and new business in Spain.
Transformation initiatives to deliver €50m cost savings (2022-2026), including 500 net FTE reductions and process automation.
Financial policy aims for maximum leverage of 3.0x, with dividend resumption in 2025 subject to leverage targets.
Latest events from doValue
- EBITDA ex-NRI up 32% YoY, net income ex-NRI tripled, and leverage improved to 2.0x.DOV
Q4 202527 Feb 2026 - EBITDA beat expectations in H1 2024 as the Gardant deal advanced and transformation continued.DOV
Q2 20242 Feb 2026 - Exceeded €8bn new GBV, confirmed guidance, and advanced the Gardant acquisition.DOV
Q3 202415 Jan 2026 - 2024 targets exceeded with €10bn new GBV, €165m EBITDA ex-NRI, and improved leverage.DOV
Q4 20241 Dec 2025 - Record revenue and EBITDA growth, strong cash flow, and digital expansion via coeo acquisition.DOV
Q2 202523 Nov 2025 - Revenues up 46% YoY, EBITDA ex-NRI doubled, and new business GBV exceeded targets.DOV
Q1 202521 Nov 2025 - Transformative €350M acquisition accelerates digital growth, diversification, and EPS accretion.DOV
M&A Announcement16 Nov 2025 - EBITDA ex-NRI up 43% YoY, net income ex-NRI doubled, and FY guidance confirmed.DOV
Q3 202512 Nov 2025 - doValue's Gardant acquisition creates a €130bn GBV credit management leader in Southern Europe.DOV
M&A Presentation13 Jun 2025